A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Clinical trial NCT03915964 · COMPLETED

Trial details

NCT number: NCT03915964
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2019-04-25
Primary completion: 2025-05-28
Enrollment: 2659

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.